Case Control in Sarcopenia Among Elderly Type 2 Diabetic Patients

Asessment of Sarcopenia Among Elderly Type 2 Diabetic Patients

1. Assess sarcopenia prevalence in elderly diabetic patients.
2. Evaluate impact of diabetes and its medications on muscle health.
3. detect effect of sacropenia on quality of life on elderly

1. Inclusion criteria:

   The study will included all patient ,age ≥ 60 years,diagnosed with type 2 diabetes mellitus at least 5 years duraation according to ADA guideline referance(8) (diabetes can be made if a patient's A1C is 6.5% or higher, their FPG is 126 mg/dL or higher, or their 2-hour plasma glucose during an OGTT is 200 mg/dL or higher. A random plasma glucose of 200 mg/dL or higher, in conjunction with classic symptoms of hyperglycemia, also indicates diabetes)

   ●Able to give informed consent

2. Exclusion criteria:

   • chronic renal disease
   • chronic liver disese
   • Severe cognitive impairment
   • Known neuromuscular diseases affecting mobility
   • malignancy Data of the study will collected over one year duration from 1/2026 _1/2027